Validation of CyTOF Against Flow Cytometry for Immunological Studies and Monitoring of Human Cancer Clinical Trials

Flow cytometry is a widely applied approach for exploratory immune profiling and biomarker discovery in cancer and other diseases. However, flow cytometry is limited by the number of parameters that can be simultaneously analyzed, severely restricting its utility. Recently, the advent of mass cytome...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Front Oncol
Päätekijät: Gadalla, Ramy, Noamani, Babak, MacLeod, Bethany L., Dickson, Russell J., Guo, Mengdi, Xu, Wenxi, Lukhele, Sabelo, Elsaesser, Heidi J., Razak, Albiruni R. Abdul, Hirano, Naoto, McGaha, Tracy L., Wang, Ben, Butler, Marcus, Guidos, Cynthia J., Ohashi, Pam S., Siu, Lillian L., Brooks, David G.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Frontiers Media S.A. 2019
Aiheet:
Oncology
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6534060/
https://ncbi.nlm.nih.gov/pubmed/31165047
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.00415
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia